3.19.3.a.u2 html 266 399 1 false 91 0 false 10 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.acceleronpharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.acceleronpharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.acceleronpharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.acceleronpharma.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 1003000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.acceleronpharma.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 1003501 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.acceleronpharma.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.acceleronpharma.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Nature of Business Sheet http://www.acceleronpharma.com/role/NatureOfBusiness Nature of Business Notes 8 false false R9.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2103100 - Disclosure - Property and Equipment, Net Sheet http://www.acceleronpharma.com/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 10 false false R11.htm 2104100 - Disclosure - Restricted Cash Sheet http://www.acceleronpharma.com/role/RestrictedCash Restricted Cash Notes 11 false false R12.htm 2105100 - Disclosure - Cash, Cash Equivalents and Short-term and Long-term Investments Sheet http://www.acceleronpharma.com/role/CashCashEquivalentsAndShortTermAndLongTermInvestments Cash, Cash Equivalents and Short-term and Long-term Investments Notes 12 false false R13.htm 2106100 - Disclosure - Accrued Expenses Sheet http://www.acceleronpharma.com/role/AccruedExpenses Accrued Expenses Notes 13 false false R14.htm 2107100 - Disclosure - Warrants Sheet http://www.acceleronpharma.com/role/Warrants Warrants Notes 14 false false R15.htm 2108100 - Disclosure - Commitments and Contingencies Sheet http://www.acceleronpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 2109100 - Disclosure - Stockholders' Equity Sheet http://www.acceleronpharma.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 2110100 - Disclosure - Significant Agreements Sheet http://www.acceleronpharma.com/role/SignificantAgreements Significant Agreements Notes 17 false false R18.htm 2111100 - Disclosure - Stock-Based Compensation Sheet http://www.acceleronpharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 2112100 - Disclosure - 401(k) Savings Plan Sheet http://www.acceleronpharma.com/role/A401KSavingsPlan 401(k) Savings Plan Notes 19 false false R20.htm 2113100 - Disclosure - Income Taxes Sheet http://www.acceleronpharma.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 2114100 - Disclosure - Leases Sheet http://www.acceleronpharma.com/role/Leases Leases Notes 21 false false R22.htm 2115100 - Disclosure - Related Party Transactions Sheet http://www.acceleronpharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 22 false false R23.htm 2116100 - Disclosure - Quarterly Financial Data (unaudited) Sheet http://www.acceleronpharma.com/role/QuarterlyFinancialDataUnaudited Quarterly Financial Data (unaudited) Notes 23 false false R24.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 2303301 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.acceleronpharma.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.acceleronpharma.com/role/PropertyAndEquipmentNet 26 false false R27.htm 2304301 - Disclosure - Restricted Cash (Tables) Sheet http://www.acceleronpharma.com/role/RestrictedCashTables Restricted Cash (Tables) Tables http://www.acceleronpharma.com/role/RestrictedCash 27 false false R28.htm 2305301 - Disclosure - Cash, Cash Equivalents and Short-term and Long-term Investments (Tables) Sheet http://www.acceleronpharma.com/role/CashCashEquivalentsAndShortTermAndLongTermInvestmentsTables Cash, Cash Equivalents and Short-term and Long-term Investments (Tables) Tables http://www.acceleronpharma.com/role/CashCashEquivalentsAndShortTermAndLongTermInvestments 28 false false R29.htm 2306301 - Disclosure - Accrued Expenses (Tables) Sheet http://www.acceleronpharma.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.acceleronpharma.com/role/AccruedExpenses 29 false false R30.htm 2307301 - Disclosure - Warrants (Tables) Sheet http://www.acceleronpharma.com/role/WarrantsTables Warrants (Tables) Tables http://www.acceleronpharma.com/role/Warrants 30 false false R31.htm 2309301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.acceleronpharma.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.acceleronpharma.com/role/StockholdersEquity 31 false false R32.htm 2311301 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.acceleronpharma.com/role/StockBasedCompensation 32 false false R33.htm 2313301 - Disclosure - Income Taxes (Tables) Sheet http://www.acceleronpharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.acceleronpharma.com/role/IncomeTaxes 33 false false R34.htm 2314301 - Disclosure - Leases (Tables) Sheet http://www.acceleronpharma.com/role/LeasesTables Leases (Tables) Tables http://www.acceleronpharma.com/role/Leases 34 false false R35.htm 2316301 - Disclosure - Quarterly Financial Data (unaudited) (Tables) Sheet http://www.acceleronpharma.com/role/QuarterlyFinancialDataUnauditedTables Quarterly Financial Data (unaudited) (Tables) Tables http://www.acceleronpharma.com/role/QuarterlyFinancialDataUnaudited 35 false false R36.htm 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 2402404 - Disclosure - Summary of Significant Accounting Policies - Schedule of Financial Instruments Carried at Fair Value (Details) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfFinancialInstrumentsCarriedAtFairValueDetails Summary of Significant Accounting Policies - Schedule of Financial Instruments Carried at Fair Value (Details) Details 37 false false R38.htm 2402405 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Fair Value of Preferred and Common Stock Warrants (Details) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInFairValueOfPreferredAndCommonStockWarrantsDetails Summary of Significant Accounting Policies - Summary of Changes in the Fair Value of Preferred and Common Stock Warrants (Details) Details 38 false false R39.htm 2402406 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details) Details 39 false false R40.htm 2402407 - Disclosure - Summary of Significant Accounting Policies - Schedule of Anti-dilutive Common Stock Equivalents Excluded from the Calculation of Diluted Net Income (Loss) per Share (Details) Sheet http://www.acceleronpharma.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAntiDilutiveCommonStockEquivalentsExcludedFromCalculationOfDilutedNetIncomeLossPerShareDetails Summary of Significant Accounting Policies - Schedule of Anti-dilutive Common Stock Equivalents Excluded from the Calculation of Diluted Net Income (Loss) per Share (Details) Details 40 false false R41.htm 2403402 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Sheet http://www.acceleronpharma.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Details 41 false false R42.htm 2404402 - Disclosure - Restricted Cash (Details) Sheet http://www.acceleronpharma.com/role/RestrictedCashDetails Restricted Cash (Details) Details http://www.acceleronpharma.com/role/RestrictedCashTables 42 false false R43.htm 2404403 - Disclosure - Restricted Cash - Narrative (Details) Sheet http://www.acceleronpharma.com/role/RestrictedCashNarrativeDetails Restricted Cash - Narrative (Details) Details 43 false false R44.htm 2405402 - Disclosure - Cash, Cash Equivalents and Short-term and Long-term Investments - Schedule of Available-for-Sale Securities (Details) Sheet http://www.acceleronpharma.com/role/CashCashEquivalentsAndShortTermAndLongTermInvestmentsScheduleOfAvailableForSaleSecuritiesDetails Cash, Cash Equivalents and Short-term and Long-term Investments - Schedule of Available-for-Sale Securities (Details) Details 44 false false R45.htm 2406402 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://www.acceleronpharma.com/role/AccruedExpensesScheduleOfAccruedExpensesDetails Accrued Expenses - Schedule of Accrued Expenses (Details) Details 45 false false R46.htm 2407402 - Disclosure - Warrants - Summary of Shares Issuable Upon Exercise of Outstanding Warrants (Details) Sheet http://www.acceleronpharma.com/role/WarrantsSummaryOfSharesIssuableUponExerciseOfOutstandingWarrantsDetails Warrants - Summary of Shares Issuable Upon Exercise of Outstanding Warrants (Details) Details 46 false false R47.htm 2409402 - Disclosure - Stockholders' Equity (Details) Sheet http://www.acceleronpharma.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.acceleronpharma.com/role/StockholdersEquityTables 47 false false R48.htm 2409403 - Disclosure - Stockholders' Equity - Schedule of Common Stock Reserved for Future Issuance (Details) Sheet http://www.acceleronpharma.com/role/StockholdersEquityScheduleOfCommonStockReservedForFutureIssuanceDetails Stockholders' Equity - Schedule of Common Stock Reserved for Future Issuance (Details) Details 48 false false R49.htm 2410401 - Disclosure - Significant Agreements - Sotatercept Agreement (Details) Sheet http://www.acceleronpharma.com/role/SignificantAgreementsSotaterceptAgreementDetails Significant Agreements - Sotatercept Agreement (Details) Details 49 false false R50.htm 2410402 - Disclosure - Significant Agreements - REBLOZYL Agreement (Details) Sheet http://www.acceleronpharma.com/role/SignificantAgreementsReblozylAgreementDetails Significant Agreements - REBLOZYL Agreement (Details) Details 50 false false R51.htm 2410403 - Disclosure - Significant Agreements - Accounting Analysis (Details) Sheet http://www.acceleronpharma.com/role/SignificantAgreementsAccountingAnalysisDetails Significant Agreements - Accounting Analysis (Details) Details 51 false false R52.htm 2410404 - Disclosure - Significant Agreements - Other (Details) Sheet http://www.acceleronpharma.com/role/SignificantAgreementsOtherDetails Significant Agreements - Other (Details) Details 52 false false R53.htm 2411402 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.acceleronpharma.com/role/StockBasedCompensationTables 53 false false R54.htm 2411403 - Disclosure - Stock-Based Compensation - Schedule of Total Compensation Cost Recognized for All Stock-based Awards (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfTotalCompensationCostRecognizedForAllStockBasedAwardsDetails Stock-Based Compensation - Schedule of Total Compensation Cost Recognized for All Stock-based Awards (Details) Details 54 false false R55.htm 2411404 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfStockOptionValuationAssumptionsDetails Stock-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details) Details 55 false false R56.htm 2411405 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 56 false false R57.htm 2411406 - Disclosure - Stock-based Compensation - Schedule of Restricted Stock Unit Activity and Performance-Based Restricted Stock Units (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfRestrictedStockUnitActivityAndPerformanceBasedRestrictedStockUnitsDetails Stock-based Compensation - Schedule of Restricted Stock Unit Activity and Performance-Based Restricted Stock Units (Details) Details 57 false false R58.htm 2412401 - Disclosure - 401(k) Savings Plan (Details) Sheet http://www.acceleronpharma.com/role/A401KSavingsPlanDetails 401(k) Savings Plan (Details) Details http://www.acceleronpharma.com/role/A401KSavingsPlan 58 false false R59.htm 2413402 - Disclosure - Income Taxes (Details) Sheet http://www.acceleronpharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.acceleronpharma.com/role/IncomeTaxesTables 59 false false R60.htm 2413403 - Disclosure - Income Taxes Income Taxes - Components of the Company's Deferred Tax Assets (Details) Sheet http://www.acceleronpharma.com/role/IncomeTaxesIncomeTaxesComponentsOfCompanysDeferredTaxAssetsDetails Income Taxes Income Taxes - Components of the Company's Deferred Tax Assets (Details) Details 60 false false R61.htm 2413404 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://www.acceleronpharma.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 61 false false R62.htm 2414402 - Disclosure - Leases - Narrative (Details) Sheet http://www.acceleronpharma.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 62 false false R63.htm 2414403 - Disclosure - Leases - Minimum Lease Payments (Details) Sheet http://www.acceleronpharma.com/role/LeasesMinimumLeasePaymentsDetails Leases - Minimum Lease Payments (Details) Details 63 false false R64.htm 2414404 - Disclosure - Leases - Lease Costs (Details) Sheet http://www.acceleronpharma.com/role/LeasesLeaseCostsDetails Leases - Lease Costs (Details) Details 64 false false R65.htm 2414405 - Disclosure - Leases - Maturity Schedule Prior to the Adoptions of ASC 842 (Details) Sheet http://www.acceleronpharma.com/role/LeasesMaturitySchedulePriorToAdoptionsOfAsc842Details Leases - Maturity Schedule Prior to the Adoptions of ASC 842 (Details) Details 65 false false R66.htm 2415401 - Disclosure - Related Party Transactions (Details) Sheet http://www.acceleronpharma.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.acceleronpharma.com/role/RelatedPartyTransactions 66 false false R67.htm 2416402 - Disclosure - Quarterly Financial Data (unaudited) (Details) Sheet http://www.acceleronpharma.com/role/QuarterlyFinancialDataUnauditedDetails Quarterly Financial Data (unaudited) (Details) Details http://www.acceleronpharma.com/role/QuarterlyFinancialDataUnauditedTables 67 false false R9999.htm Uncategorized Items - xlrn-20191231x10k.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - xlrn-20191231x10k.htm Cover 68 false false All Reports Book All Reports xlrn-20191231x10k.htm xlrn-20191231.xsd xlrn-20191231_cal.xml xlrn-20191231_def.xml xlrn-20191231_lab.xml xlrn-20191231_pre.xml xlrn-20191231xex1019.htm xlrn-20191231xex1021.htm xlrn-20191231xex1022.htm xlrn-20191231xex211.htm xlrn-20191231xex231.htm xlrn-20191231xex311.htm xlrn-20191231xex312.htm xlrn-20191231xex321.htm xlrn-20191231xex44.htm pipeline2020a01.jpg totalreturnchart2019.jpg http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true